What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.30%Below 5Y avg (1.58%)
Annual Rate
KRW 600.00Paid annual
Payout Ratio
26.4%Sustainable
Last Ex-Dividend
Feb 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
29.91TKRW
21.24B · vs all stocks (USD)
Updated Aug 8, 2026
Trailing P/E
104.18x
Updated Aug 8, 2026
Revenue (TTM)
5.31TKRW
3.77B · vs all stocks (USD)
Updated Aug 8, 2026
Profit Margin
6.35%
Updated Aug 8, 2026
Beta
1.83x
vs all stocks
Updated Aug 8, 2026
52-Week Change
221.09%
vs all stocks
Updated Aug 8, 2026
Market Capitalization
29.91TKRW
21.24B · vs all stocks (USD)
Updated Aug 8, 2026
Enterprise Value
30.58TKRW
21.72B · vs all stocks (USD)
Updated Aug 8, 2026
Trailing P/E
104.18x
Updated Aug 8, 2026
Forward P/E
39.91x
Updated Aug 8, 2026
PEG Ratio
1.44x
Updated Aug 8, 2026
Price to Sales (TTM)
5.63x
Updated Aug 8, 2026
Price to Book (MRQ)
14.00x
Updated Aug 8, 2026
Enterprise to Revenue
5.76x
Updated Aug 8, 2026
Enterprise to EBITDA
51.21x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 45.51×.Updated Aug 8, 2026
Gross Margin
21.25%
Updated Aug 8, 2026
Profit Margin
6.35%
Updated Aug 8, 2026
Operating Margin
9.19%
Updated Aug 8, 2026
Return on Assets (TTM)
5.75%
Updated Aug 8, 2026
Return on Equity (TTM)
16.67%
Updated Aug 8, 2026
Revenue (TTM)
5.31TKRW
3.77B · vs all stocks (USD)
Updated Aug 8, 2026
Revenue per Share (TTM)
35.73KKRWUpdated Aug 8, 2026
Quarterly Revenue Growth
33.40%
Updated Aug 8, 2026
Gross Profit (TTM)
1.12TKRW
794.37M · vs all stocks (USD)
Updated Aug 8, 2026
EBITDA (TTM)
671.86BKRW
477.28M · vs all stocks (USD)
Updated Aug 8, 2026
Net Income (TTM)
337.26BKRW
239.58M · vs all stocks (USD)
Updated Aug 8, 2026
Quarterly Earnings Growth (YoY)
72.50%
Updated Aug 8, 2026
Operating Cash Flow (TTM)
187.97BKRW
133.53M · vs all stocks (USD)
Updated Aug 8, 2026
Levered Free Cash Flow (TTM)
-33.21BKRW
-23.59M · vs all stocks (USD)
Updated Aug 8, 2026
Trailing Annual Dividend Rate
600.00KRWUpdated Aug 8, 2026
Trailing Annual Dividend Yield
0.30%
vs all stocks
Updated Aug 8, 2026
5-Year Average Dividend Yield
1.58%
vs all stocks
Updated Aug 8, 2026
Payout Ratio
26.44%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 31.1%.Updated Aug 8, 2026
Minority Interest (Equity)
71.53BKRWFY2025 · Dec 31, 2025
Revenue
4.97TKRWFY2025 · Dec 31, 2025
Cost of Goods Sold
3.91TKRWFY2025 · Dec 31, 2025
Gross Profit
1.05TKRWFY2025 · Dec 31, 2025
Operating Income
426.52BKRW
302.99M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
410.07BKRWFY2025 · Dec 31, 2025
Income Tax Expense
125.81BKRWFY2025 · Dec 31, 2025
Net Income
284.26BKRWFY2025 · Dec 31, 2025
EBIT
462.27BKRWFY2025 · Dec 31, 2025
EBITDA (Income Statement)
570.63BKRWFY2025 · Dec 31, 2025
Research & Development
93.13BKRWFY2025 · Dec 31, 2025
Selling, General & Administrative
156.67BKRWFY2025 · Dec 31, 2025
Other Operating Expenses
63.57BKRWFY2025 · Dec 31, 2025
Non-operating Interest Income
22.06BKRWFY2025 · Dec 31, 2025
Non-operating Interest Expense
52.20BKRWFY2025 · Dec 31, 2025
EPS (Basic)
1.93KKRWFY2025 · Dec 31, 2025
EPS (Diluted)
1.93KKRWFY2025 · Dec 31, 2025
Basic Shares Outstanding
148.56MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
148.56MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
284.26BKRWFY2025 · Dec 31, 2025
Minority Interests (P&L)
2.37BKRWFY2025 · Dec 31, 2025
Operating Cash Flow
167.88BKRWFY2025 · Dec 31, 2025
Free Cash Flow
-32.35BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
762.72BKRWFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
284.26BKRWFY2025 · Dec 31, 2025
Stock-based Compensation
10.51BKRWFY2025 · Dec 31, 2025
Other Non-cash Items
49.21BKRWFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-120.29BKRWFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-55.81BKRWFY2025 · Dec 31, 2025
Capital Expenditures
-200.23BKRWFY2025 · Dec 31, 2025
Net Intangibles (CF)
-8.36BKRWFY2025 · Dec 31, 2025
Net Acquisitions
-13.06BKRWFY2025 · Dec 31, 2025
Purchase of Investments
-63.46BKRWFY2025 · Dec 31, 2025
Sale of Investments
42.34BKRWFY2025 · Dec 31, 2025
Other Investing Activity
-6.97BKRWFY2025 · Dec 31, 2025
Net Investing Cash Flow
-241.38BKRWFY2025 · Dec 31, 2025
Long-term Debt Issuance
473.57BKRWFY2025 · Dec 31, 2025
Long-term Debt Payments
-735.03BKRWFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
-323.80BKRWFY2025 · Dec 31, 2025
Common Dividends Paid
-87.40BKRWFY2025 · Dec 31, 2025
Other Financing Charges
-59.81MKRWFY2025 · Dec 31, 2025
Net Financing Cash Flow
-672.72BKRWFY2025 · Dec 31, 2025
Shares Outstanding
148.69MSharesUpdated Aug 8, 2026
Float Shares
75.91MSharesUpdated Aug 8, 2026
% Held by Insiders
48.53%
vs all stocks
Updated Aug 8, 2026
% Held by Institutions
26.37%
vs all stocks
Updated Aug 8, 2026
Total Cash (MRQ)
830.73BKRW
590.13M · vs all stocks (USD)
Updated Aug 8, 2026
Total Cash per Share (MRQ)
5.59KKRWUpdated Aug 8, 2026
Total Debt (MRQ)
1.45TKRW
1.03B · vs all stocks (USD)
Updated Aug 8, 2026
Total Debt to Equity (MRQ)
0.6799x
Updated Aug 8, 2026
Current Ratio (MRQ)
1.61x
Updated Aug 8, 2026
Book Value per Share (MRQ)
14.35KKRWUpdated Aug 8, 2026
Total Assets
4.96TKRW
3.52B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
3.36TKRWFY2025 · Dec 31, 2025
Total Liabilities
2.82TKRWFY2025 · Dec 31, 2025
Total Non-current Assets
1.60TKRWFY2025 · Dec 31, 2025
Total Non-current Liabilities
950.72BKRWFY2025 · Dec 31, 2025
Total Current Liabilities
1.86TKRWFY2025 · Dec 31, 2025
Cash Equivalents
762.72BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents
762.72BKRWFY2025 · Dec 31, 2025
Other Short-term Investments
65.20BKRWFY2025 · Dec 31, 2025
Accounts Receivable
982.45BKRWFY2025 · Dec 31, 2025
Inventory
552.89BKRWFY2025 · Dec 31, 2025
Accounts Payable
440.04BKRWFY2025 · Dec 31, 2025
Short-term Debt
596.73BKRWFY2025 · Dec 31, 2025
Other Current Liabilities
1.32BKRWFY2025 · Dec 31, 2025
Long-term Debt
792.84BKRWFY2025 · Dec 31, 2025
Other Non-current Liabilities
320.00KRWFY2025 · Dec 31, 2025
Common Stock (Book)
150.00BKRWFY2025 · Dec 31, 2025
Retained Earnings
1.94TKRWFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.14TKRW
1.52B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
9.90BKRWFY2025 · Dec 31, 2025
52-Week Low
50.60KKRWUpdated Aug 8, 2026
52-Week High
335.00KKRWUpdated Aug 8, 2026
52-Week Change
221.09%
vs all stocks
Updated Aug 8, 2026
Beta
1.83x
vs all stocks
Updated Aug 8, 2026
50-Day MA
220.01KKRWUpdated Aug 8, 2026
200-Day MA
160.69KKRWUpdated Aug 8, 2026
Avg 10-Day Volume
954.65KSharesUpdated Aug 8, 2026
Avg 30-Day Volume
1.01MSharesUpdated Aug 8, 2026
Diluted EPS (TTM)
1.93KKRWUpdated Aug 8, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
Where is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 8.59: safe zoneNotable
Altman Z-Score: 8.59
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $21.24B, above the global median of $1.15BNotable
Market cap (USD): 21,244,521,523.533Global Median: 1,146,734,693.424
Revenue is $3.77B, above the global median of $520.53MNotable
Multi-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown
Multi-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown
Multi-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And Drawdown